Year: 2021
Language: Arabic
This resource is also available in: الإنجليزية الفرنسية الروسية الأسبانية
Author(s): World Federation of Hemophilia
Format: Video
In this session from the Global Policy and Access Summit, Dawn Rotellini, Mark Skinner, Jamie O’Hara and David Page will present an overview of the current state of access to therapies for people with bleeding disorders. Speakers will also highlight the importance of patient-relevant data on treatment choices and health policy decision-making. Session will include a case study and concrete recommendations will be brought forward for patient organizations to advocate for increased access to therapies.
This WFH session was originally presented in English.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
تتمحوَر عروض ونقاشات النسخة الثالثة من القمّة العالميّة للسياسات والقدرة على الوصول للاتحاد العالمي للهيموفيليا حول زيادة القدرة على الحصول
ستدور عروض ومناقشات النسخة الثانية من القمة العالمية للسياسات والقدرة على الوصول للاتحاد العالمي للهيموفيليا حول تحسين الرعاية و الحصول
In this session from the Global Policy and Access Summit, Donna Coffin, Salome Mekhuzla, Carlos Safadi Marquez, John Gershman and
In this session from the Global Policy and Access Summit, Dan Hart, Margareth Ozelo, Hatoon Mohammed and Daniel Anibal Garcia
In this session from the Global Policy and Access Summit, Dawn Rotellini, Bradley Rayner, Declan Noone and Durhane Wong-Rieger, will
How is the pandemic impacting global healthcare systems around the world? What will the “new normal” be? In this opening
